Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Marker Therapeutics Announced The Preliminary Results Of The First Participant Treated With MT-601, Its Multi-tumor Associated Antigen-specific T Cell Product Targeting 6 Taas, In The Phase 1 Multicenter APOLLO Trial

Author: Benzinga Newsdesk | September 11, 2023 07:04am

Posted In: MRKR